In this episode, Jesse speaks with Professor Richard Faragher, one of the UK’s leading researchers on the biology of aging. They dive deep into why only 18% of people age well, what it means to age badly, and how emerging science is changing our understanding of aging itself.

Topics include:

• The biological and economic toll of aging
• Evidence that aging is “druggable”
• Promising research on rapamycin, metformin, and senolytics
• Why repurposed drugs could extend healthy lifespan today
• Challenges with clinical trials and drug development costs
• Social and economic divides in access to anti-aging therapies
• The role of loneliness, purpose, and lifestyle in aging
• How aging compares to other diseases in public perception and funding
• The potential for aging interventions to delay multiple diseases at once
• What individuals can do now to age better
• Faragher also reflects on the political and commercial future of anti-aging medicine—and the race to control its patents.

Guest Bio: Dr. Richard Faragher is a professor of biogerontology at the University of Brighton. His research focuses on cellular senescence and the mechanisms of aging, and he’s a leading advocate for translating aging science into real-world interventions.

📺Watch the full pod on YouTube 📺https://youtu.be/x6Nru2NkFEM

🎙 The Pod is hosted by Jesse Wright
💬 For guest suggestions, questions, or media inquiries, reach out at https://elpodcast.media/
📬 Never miss an episode – subscribe and follow wherever you get your podcasts.
⭐️ If you enjoyed this episode, please rate and review the show. It helps others find us.
 

Thanks for listening!